Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.55EUR
62.37 MEUR
1.14 BEUR
16.96 M
About DERMAPHARM HLDG SE
Sector
CEO
Hans-Georg Feldmeier
Headquarters
Grunwald
Website
Founded
2017
ISIN
DE000A2GS5D8
FIGI
BBG01Q6C2C18
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DMP is 31.25 EUR — it has decreased by −1.73% in the past 24 hours. Watch DERMAPHARM HOLDING SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange DERMAPHARM HOLDING SE stocks are traded under the ticker DMP.
DMP stock has fallen by −2.19% compared to the previous week, the month change is a −10.71% fall, over the last year DERMAPHARM HOLDING SE has showed a −10.71% decrease.
We've gathered analysts' opinions on DERMAPHARM HOLDING SE future price: according to them, DMP price has a max estimate of 58.00 EUR and a min estimate of 41.50 EUR. Watch DMP chart and read a more detailed DERMAPHARM HOLDING SE stock forecast: see what analysts think of DERMAPHARM HOLDING SE and suggest that you do with its stocks.
DMP stock is 2.25% volatile and has beta coefficient of 0.62. Track DERMAPHARM HOLDING SE stock price on the chart and check out the list of the most volatile stocks — is DERMAPHARM HOLDING SE there?
Today DERMAPHARM HOLDING SE has the market capitalization of 1.71 B, it has increased by 1.56% over the last week.
Yes, you can track DERMAPHARM HOLDING SE financials in yearly and quarterly reports right on TradingView.
DERMAPHARM HOLDING SE is going to release the next earnings report on Nov 14, 2024. Keep track of upcoming events with our Earnings Calendar.
DERMAPHARM HOLDING SE revenue for the last quarter amounts to 279.80 M EUR, despite the estimated figure of 279.80 M EUR. In the next quarter, revenue is expected to reach 296.30 M EUR.
DMP net income for the last quarter is 17.27 M EUR, while the quarter before that showed 43.62 M EUR of net income which accounts for −60.41% change. Track more DERMAPHARM HOLDING SE financial stats to get the full picture.
Yes, DMP dividends are paid annually. The last dividend per share was 0.88 EUR. As of today, Dividend Yield (TTM)% is 2.77%. Tracking DERMAPHARM HOLDING SE dividends might help you take more informed decisions.
DERMAPHARM HOLDING SE dividend yield was 2.08% in 2023, and payout ratio reached 75.97%. The year before the numbers were 2.80% and 42.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DERMAPHARM HOLDING SE EBITDA is 294.89 M EUR, and current EBITDA margin is 26.86%. See more stats in DERMAPHARM HOLDING SE financial statements.
Like other stocks, DMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DERMAPHARM HOLDING SE stock right from TradingView charts — choose your broker and connect to your account.